Ealla K, Durga C, Sahu V, Kumari N, Venkatesan J, Veeraraghavan V
BMC Oral Health. 2025; 25(1):177.
PMID: 39893416
PMC: 11787760.
DOI: 10.1186/s12903-025-05568-4.
Mansor M, Gao Z, Howard F, MacInnes J, Zhao X, Muthana M
Pharmaceutics. 2025; 17(1).
PMID: 39861742
PMC: 11768208.
DOI: 10.3390/pharmaceutics17010095.
Maia M, Egito E, Sapin-Minet A, Viana D, Kakkar A, Soares D
Molecules. 2025; 30(2).
PMID: 39860198
PMC: 11767523.
DOI: 10.3390/molecules30020328.
Cheng L, Zhang Y, Xu Q, Li Z, Liu Z, Dai F
Int J Pharm X. 2025; 9():100312.
PMID: 39802890
PMC: 11722578.
DOI: 10.1016/j.ijpx.2024.100312.
Bhat U, Khan N, Raza S, Ali M, Mehdi S, Mohiuddin I
Heliyon. 2024; 10(22):e38777.
PMID: 39619581
PMC: 11605355.
DOI: 10.1016/j.heliyon.2024.e38777.
Cuproptosis-based layer-by-layer silk fibroin nanoplatform-loaded PD-L1 siRNA combining photothermal and chemodynamic therapy against metastatic breast cancer.
Li Z, Cheng L, Xu X, Jia R, Zhu S, Zhang Q
Mater Today Bio. 2024; 29:101298.
PMID: 39469315
PMC: 11513806.
DOI: 10.1016/j.mtbio.2024.101298.
Electrospun Silk-ICG Composite Fibers and the Application toward Hemorrhage Control.
Siddiqua A, Clutter E, Garklavs O, Kanniyappan H, Wang R
J Funct Biomater. 2024; 15(9).
PMID: 39330247
PMC: 11433354.
DOI: 10.3390/jfb15090272.
Inhalable drug-loaded silk fibroin carriers for pulmonary drug delivery.
DOnofrio I, De Giorgio G, Sajapin R, Vurro D, Liboa A, Dembech E
RSC Adv. 2024; 14(37):27288-27297.
PMID: 39219844
PMC: 11362913.
DOI: 10.1039/d4ra03324h.
Ultrasonication-Assisted Green Synthesis and Physicochemical and Cytotoxic Activity Characterization of Protein-Based Nanoparticles from Seeds.
Nafeh A, Mohamed I, Foda M
Nanomaterials (Basel). 2024; 14(15).
PMID: 39120359
PMC: 11313732.
DOI: 10.3390/nano14151254.
Enhancing the Bioavailability of Resveratrol: Combine It, Derivatize It, or Encapsulate It?.
Salla M, Karaki N, El Kaderi B, Ayoub A, Younes S, Abou Chahla M
Pharmaceutics. 2024; 16(4).
PMID: 38675230
PMC: 11053528.
DOI: 10.3390/pharmaceutics16040569.
Applications and Potentials of a Silk Fibroin Nanoparticle Delivery System in Animal Husbandry.
Guo Y, Awais M, Fei S, Xia J, Sun J, Feng M
Animals (Basel). 2024; 14(4).
PMID: 38396623
PMC: 10885876.
DOI: 10.3390/ani14040655.
Silk Fibroin Materials: Biomedical Applications and Perspectives.
De Giorgio G, Matera B, Vurro D, Manfredi E, Galstyan V, Tarabella G
Bioengineering (Basel). 2024; 11(2).
PMID: 38391652
PMC: 10886036.
DOI: 10.3390/bioengineering11020167.
mRNA Delivery: Challenges and Advances through Polymeric Soft Nanoparticles.
Yousefi Adlsadabad S, Hanrahan J, Kakkar A
Int J Mol Sci. 2024; 25(3).
PMID: 38339015
PMC: 10855060.
DOI: 10.3390/ijms25031739.
Degradable Polymeric Bio(nano)materials and Their Biomedical Applications: A Comprehensive Overview and Recent Updates.
Kuperkar K, Atanase L, Bahadur A, Crivei I, Bahadur P
Polymers (Basel). 2024; 16(2).
PMID: 38257005
PMC: 10818796.
DOI: 10.3390/polym16020206.
Advanced Applications of Silk-Based Hydrogels for Tissue Engineering: A Short Review.
Akdag Z, Ulag S, Kalaskar D, Duta L, Gunduz O
Biomimetics (Basel). 2023; 8(8).
PMID: 38132551
PMC: 10742028.
DOI: 10.3390/biomimetics8080612.
Biomaterials-mediated CRISPR/Cas9 delivery: recent challenges and opportunities in gene therapy.
Dubey A, Mostafavi E
Front Chem. 2023; 11:1259435.
PMID: 37841202
PMC: 10568484.
DOI: 10.3389/fchem.2023.1259435.
Enhanced Osteogenic Potential of Knockout C2C12 Cells on BMP-2 Releasing Silk Scaffolds.
Cakmak A, Fuerkaiti S, Karaguzel D, Karaaslan C, Gumusderelioglu M
ACS Biomater Sci Eng. 2023; 9(11):6175-6185.
PMID: 37796024
PMC: 10646847.
DOI: 10.1021/acsbiomaterials.3c00506.
Pulmonary delivery of mucus-traversing PF127-modified silk fibroin nanoparticles loading with quercetin for lung cancer therapy.
Tang Y, Zhang L, Sun R, Luo B, Zhou Y, Zhang Y
Asian J Pharm Sci. 2023; 18(4):100833.
PMID: 37635802
PMC: 10450418.
DOI: 10.1016/j.ajps.2023.100833.
Relevant Properties and Potential Applications of Sericin in Bone Regeneration.
Kim J, Kim S, Garagiola U
Curr Issues Mol Biol. 2023; 45(8):6728-6742.
PMID: 37623245
PMC: 10453912.
DOI: 10.3390/cimb45080426.
Development of nanostructured formulation from naringenin and silk fibroin and application for inhibition of lipoxygenase (LOX).
Holanda F, Pereira R, Marinho V, Jimenez D, Costa Ferreira L, Ribeiro-Costa R
RSC Adv. 2023; 13(33):23063-23075.
PMID: 37529367
PMC: 10388158.
DOI: 10.1039/d3ra02374e.